Teen Drinking May Have Long-Term Effects
Drinking alcohol in your late teen years could lead to liver problems in your adult years, according to a new study.
FDA Issues Warning for Liver Rx
The US Food and Drug Administration (FDA) is warning that a medication for a rare liver disease could pose deadly risks to some patients.
Why the Hepatitis C 'Cure' Rate Spiked
Hepatitis C "cure" rates increased 21-fold between 2010 and 2015, a new study found. That increase is likely due to a transformation in the available treatments.
Hep C, Baby Boomers and Testing
In 2015, nearly 86 percent of baby boomers had never been screened for the hepatitis C virus (HCV), a new study found. And that may put them at unnecessary risk for liver disease.
Rare Liver Disease Gets First New Rx in Years
The US Food and Drug Administration (FDA) has approved a new treatment for primary biliary cholangitis (PBC).
FDA OKs First Rx for Rare Liver Condition
The US Food and Drug Administration (FDA) has approved Defitelio (defibrotide sodium) to treat adults and children with severe hepatic (liver) veno-occlusive disease (VOD).
Diabetes Rx Kept Fatty Liver at Bay
A medication used in the treatment of type 2 diabetes may have the power to combat another common condition.
Metabolic Syndrome — A Cardiac Crystal Ball?
A new test may be able to predict whether a child is at risk of heart disease — long before he or she ever develops it.
Drinking Soda Could Put Your Liver on the Rocks
Liver damage is often linked with alcohol abuse, but sugary non-alcoholic drinks may also pack a toxic punch.
Metabolic Syndrome Rate Stabilizing
A cluster of health problems — collectively known as metabolic syndrome — puts many at possible risk for heart disease and stroke. The good news? Rates for this condition appear to be stabilizing in the US.